Induced Psychosis: a Rising Problems in Clozapine in University Malaya Medical Malaysia
Total Page:16
File Type:pdf, Size:1020Kb
MJP December 2008 Vol.17 No.2 Dec 2008 Vol. 17 No. 2 CONTENTS Editorial Prevalence Of Obesity, Lipid and Glucose Amphetamine Type Stimulant (ATS) Abnormalities in Outpatients Prescribed Induced Psychosis: A Rising Problems in Clozapine in University Malaya Medical Malaysia. Center, Kuala Lumpur. 3-6 37-46 Ahmad Hatim S Sharmilla T Ahmad Hatim S Original Paper Jambunathan ST Validation of the Bahasa Malaysia Impact of Psychiatry Training on Attitudes Version of the Coping Inventory for of Undergraduate Medical Students. Stressful Situation. 47-54 Chandrasekaran R 7-16 Srikumar P. S Ramli M Joshua E Mohd Ariff F Rasamy G Khalid Y Rosnani S Cross-Cultural Adaptation and Validation Social Anxiety Problem among Medical of the Bahasa Malaysia Version of the Students in Universiti Malaya Medical Eating Disorder Examination Center (UMMC) – A Cross-sectional Questionnaire (Ede-Q). Study. 55-63 Ramli M 17-22 Jamaiyah H Salina M Noor Azimah M Ng CG Khairani O Gill JS Adam B Chin JM Chin CJ Yap WF The Prevalence of Depressive Symptoms and Potential Risk Factors That May Student Learning Disability Experiences, Cause Depression among Adult Women Training and Services Needs of in Selangor. Secondary School Teachers. 64-72 23-36 Sherina MS Teoh HJ Rampal L Cheong SK Azhar MZ Woo PJ 1 MJP December 2008 Vol.17 No.2 Review Paper Book Review: Heroin Addiction: The Past and Future Antiepileptic Drugs to Treat Psychiatric 73-78 Disorders Noor Zurani MHR 88-90 Hussain H Edited by Susan L. McElroy Rusdi AR Muhammad Muhsin AZ Paul E. Keck, Jr. and Robert M. Post Is There a Need for a Hospital Based Smoking Cessation Programme in Education Paper Malaysia? 79-82 Are Our Postgraduate Candidates Having Noor Zurani MHR Knowledge Problems in Basic Sciences? Mohammad Hussain H – An Experience with Mock Multiple Choice Questions (MCQ). Case Report 91-97 Hatta Sidi Post Stroke Laughter – A Case Report. Fairuz Nazri AR 83-87 Amarpreet Kaur Nor Zuraida Z Ng CG Aida SA 2 MJP December 2008 Vol.17 No.2 EDITORIAL AMPHETAMINE TYPE STIMULANT (ATS) INDUCED PSYCHOSIS: A RISING PROBLEMS IN MALAYSIA Ahmad Hatim S Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur The past decade has seen a marked increase in the popularity of ATS use, particularly methamphetamine, within East Asia, and the Pacific region (1) In Malaysia, the National Anti Drug Agency has identified 8,870 addicts (from January till August 2008) out of which 1,126 was ATS dependence. During the same period, the police have arrested 46,388 people under the Dangerous Drug Act 1952. They also has seize 283kg of syabu, 545kg of ecstacy powder, 66194 tablets of esctacy pills and 222,376 tablets of yaba pills from Jan till August this year.(2) The occurrence of psychosis arising from the use of ATS was first reported in the late 1930’s. With growing ATS use, particularly methamphetamine, ATS-induced psychosis has become a major impact on public health. Symptoms of ATS-induced psychosis Methamphetamine use produces a variety of effects, ranging from irritability, to physical aggression, hyperawareness, hypervigilance, and psychomotor agitation. Repeated or high-dose use of the stimulant can cause drug-induced psychosis resembling paranoid schizophrenia, characterized by hallucinations, delusions and thought disorders. When used in long term, methamphetamine may lead to development of psychiatric symptoms due to dopamine depletion in the striatum. The most common lifetime psychotic symptoms among methamphetamine psychotic patients – as reported in a cross-country study (3) involving Australia, Japan, the Philippines and Thailand – are persecutory delusion, auditory hallucinations, strange or unusual beliefs and thought reading. Those patients were also reported to suffer from impaired speech, psychomotor retardation, depression and anxiety. An ATS psychosis can be distinguished from primary psychotic disorders by time. In ATS-induced psychosis symptoms usually resolve after the drug is discontinued. If symptoms do not resolve within 2 weeks after cessation of stimulant use, a primary psychiatric disorder should be suspected.(4) When compared with other stimulants, such as cocaine, psychosis is induced more commonly by ATS, possibly due to the longer duration of action produced by amphetamines. For example, while smoking cocaine produces a “high” that lasts for 20- 30 minutes, smoking methamphetamine produces a “high” that lasts 8-24 hours.(5) 3 MJP December 2008 Vol.17 No.2 Other symptoms of ATS-induced psychosis reported include affective blunting,(6) violent behavior, and self-mutilation and self-injurious behavior.(7) Duration of ATS-induced psychotic state Duration of amphetamine and methamphetamine-induced psychoses varies considerably. ATS-induced psychoses can be transient or persistent based on the duration of psychoses. In general, there are two types of methamphetamine psychosis.(8, 9) • Transient type The majority of ATS-induced psychosis is a shorter psychotic state that begins to improve along with changes in the acute central action of the stimulant. The psychotic symptoms of transient type ATS psychoses last only hours, and usually abate within a week of withdrawal from the drug. However, prolonged symptom episodes have been observed in some individuals. • Persistent type With this type of ATS psychoses, individuals experience psychotic symptoms for a considerably longer period of time. The psychotic state may last for more than 3 months and up to or beyond 6 months after cessation of drug use. Prevalence of ATS-induced psychosis ATS users are a high-risk population for psychosis.(10) Heavier methamphetamines users have been indicated to be at higher risk of psychosis compared with the general population.(9, 11) Methamphetamine users who already have a pre-existing proneness to psychosis are at particularly high risk of experiencing symptoms of psychosis. Besides at risk of developing an ATS-induced psychosis, ATS users are also more prone to developing schizophrenia and other psychotic disorders.(10) Similarly, in people who are suffering from schizophrenia, methamphetamine use can precipitate and exacerbate psychotic symptoms.(12) The high level of methamphetamine use has been associated with an increased prevalence in functional psychosis. This was demonstrated in two separate studies involving prison inmates who use stimulant drugs(11) and psychiatric patients (13) with a concurrent diagnosis of amphetamine abuse, respectively. Within these contexts, the prevalence of psychosis among individuals with amphetamine use disorder was up to 28%. A more recent Australian study (14) further showed an alarmingly high prevalence of psychosis among methamphetamine users when compared with the general population, even among those who had no known history of schizophrenia or other psychotic disorders. Among participants screened, 13% were positive for psychosis compared with 1.2% in the general population (11 times greater in prevalence), and 23% had experienced a clinically significant symptom of suspiciousness, unusual thought content or hallucinations in the past year. In addition, dependent methamphetamine users were noted to be three times more likely to have experienced psychotic symptoms than their non-dependent counterparts, even 4 MJP December 2008 Vol.17 No.2 after adjusting for history of schizophrenia and other psychotic disorders. (14) This clearly shows that dependent methamphetamine users are a particularly high-risk group for psychosis. Therefore, there is a strong need to have more local data and research on this important and rising public health problem. References 1. Farrell M, Marsden J, Ali R, Ling W. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction. 2002 Jul;97(7):771-2. 2. Laporan Dadah Jan - Ogos 2008, Agensi Anti Dadah Kebangsaan. Available at http://www.adk.gov.my/download/laporan/laporanogos.pdf. 3. Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol. 2003 Dec; 6(4):347-52. 4. Larson M. Amphetamine related psychiatric disorders. eMedicine, Jan 29 2008. Avaiable at: http://www.emedicine.com/med/topic3114.htm. 5. National Institute on Drug Abuse. Methamphetamine: abuse and addiction (NIH Publication No. 98 - 4210). Washington DC; April 1998. 6. Bell DS. Comparison Of Amphetamine Psychosis And Schizophrenia. Br J Psychiatry. 1965 Aug;111:701-7. 7. Kratofil PH, Baberg HT, Dimsdale JE. Self-mutilation and severe self-injurious behavior associated with amphetamine psychosis. Gen Hosp Psychiatry. 1996 Mar;18(2):117-20. 8. Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, Nakatani Y, et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand. 1994 Jun;89(6):428-32. 9. Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996 Jan;91(1):81-7. 10. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990 Nov 21;264(19):2511-8. 11. Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, et al. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry. 2002 Nov;181:393-8. 5 MJP December 2008 Vol.17 No.2 12. Curran C, Byrappa N, McBride A.